Adaptimmune Therapeutics Profit Margin 2015-2021 | ADAP
Current and historical gross margin, operating margin and net profit margin for Adaptimmune Therapeutics (ADAP) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Adaptimmune Therapeutics net profit margin as of September 30, 2021 is -2499.92%.
|Adaptimmune Therapeutics Annual Profit Margins
|Adaptimmune Therapeutics Quarterly Profit Margins
||Medical - Biomedical and Genetics
Adaptimmune Therapeutics plc is a biopharmaceutical company. The Company is focused on cancer immunotherapy products based on T-cell receptor platform. Adaptimmune Therapeutics plc is based in Abingdon, United Kingdom.